Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/16/2026 | $24.00 | Neutral → Underperform | BNP Paribas Exane |
| 12/17/2025 | $27.00 | Neutral → Sell | Citigroup |
| 11/7/2025 | $29.00 | Underweight | Analyst |
| 7/9/2025 | $30.00 | Sell → Neutral | Rothschild & Co Redburn |
| 6/6/2025 | $28.00 | Outperform → Neutral | BNP Paribas Exane |
| 4/9/2025 | $38.00 | Neutral → Buy | ROTH MKM |
| 4/2/2025 | $37.50 | Hold | Berenberg |
| 3/6/2025 | $47.00 → $32.00 | Equal-Weight → Underweight | Morgan Stanley |
BNP Paribas Exane downgraded Brown-Forman from Neutral to Underperform and set a new price target of $24.00
Citigroup downgraded Brown-Forman from Neutral to Sell and set a new price target of $27.00
Analyst resumed coverage of Brown-Forman with a rating of Underweight and set a new price target of $29.00
4 - BROWN FORMAN CORP (0000014693) (Issuer)
10-Q - BROWN FORMAN CORP (0000014693) (Filer)
144 - BROWN FORMAN CORP (0000014693) (Subject)
8-K - BROWN FORMAN CORP (0000014693) (Filer)
SC 13G/A - BROWN FORMAN CORP (0000014693) (Subject)
SC 13G/A - BROWN FORMAN CORP (0000014693) (Subject)
SC 13G/A - BROWN FORMAN CORP (0000014693) (Subject)